P2Et plus PD-L1 therapy showed no clear additive effect on tumor growth and other immune cell subsets in the 4T1 tumor model [193] but had a synergistic antitumor effect in B16 melanoma models along with increased leukocytes, lymphocytes, monocytes, and granulocytes [193]. This evidence concerns the gene CD274 and neoplasm.